ArticleTherapeutic advances in hematology2026
Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting.
Robert Klamroth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.